MindSet Pharma Indole Derivative Serotonergic Patent Granted
Summary
USPTO granted patent US12606543B2 to MindSet Pharma Inc. on April 21, 2026. The patent covers indole derivatives as serotonergic agents useful for activation of serotonin receptors in cells and treating diseases, disorders, or conditions including psychosis, mental illnesses, and CNS disorders.
What changed
USPTO granted patent US12606543B2 to MindSet Pharma Inc. covering indole derivatives of general Formula (I) useful as serotonergic agents. The patent protects compositions including indole derivatives and their use in activation of serotonin receptors for treating diseases, disorders, or conditions including psychosis, mental illnesses and CNS disorders.
Pharmaceutical companies developing serotonergic compounds should review this patent for freedom-to-operate considerations. The 26 granted claims cover compositions, methods of preparation, and therapeutic uses for CNS disorders.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
Grant US12606543B2 Kind: B2 Apr 21, 2026
Assignee
MINDSET PHARMA INC.
Inventors
Abdelmalik Slassi
Abstract
The present disclosure relates to indole derivatives of general Formula (I), to processes for their preparation, to compositions including indole derivatives of general Formula (I), and to their use in activation of a serotonin receptors in a cell, as well as to treating diseases, disorders, or conditions by activation of a serotonin receptors in a cell. The diseases, disorders, or conditions include, for example, psychosis, mental illnesses and CNS disorders.
CPC Classifications
C07D 403/06 C07D 405/14 C07D 409/14 A61K 31/404 A61K 31/4439
Filing Date
2025-04-25
Application No.
19189862
Claims
26
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.